More articles from Letters to the editor

  • Cervical cancer screening (November 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 164; DOI: https://doi.org/10.3949/ccjm.79c:03001

    Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).

  • In reply: Dabigatran (October 2011)
    Siddharth A. Wartak, MD and John R. Bartholomew, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 168-169; DOI: https://doi.org/10.3949/ccjm.79c:03005
  • Dabigatran (October 2011)
    Patricio A. Pazmiño, PhD, MD, FACP, FASN
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 166; DOI: https://doi.org/10.3949/ccjm.79c:03003

    Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).

  • In reply: Cervical cancer screening (November 2011)
    Xian Wen Jin, MD, PhD, FACP and Andrea Sikon, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 164; DOI: https://doi.org/10.3949/ccjm.79c:03002
  • Dabigatran (October 2011)
    Van Smith, MD, FACP
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 787; DOI: https://doi.org/10.3949/ccjm.78c.12001

    Readers comment on negative U waves (August 2011) and on dabigatran (October 2011).

  • The negative U wave in the setting of demand ischemia (August 2011)
    Promporn Suksaranjit, MD, Wisit Cheungpasitporn, MD, Edward F. Bischof, MD and Herbert Marx, MD
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 785; DOI: https://doi.org/10.3949/ccjm.78c:12003

    Readers comment on negative U waves (August 2011) and on dabigatran (October 2011).

  • In reply: Atrial fibrillation management: Issues of concern (April 2011)
    Thomas Callahan, MD and Brian Baranowski, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 720-721; DOI: https://doi.org/10.3949/ccjm.78c.1102
  • In reply: Angioedema due to the renin inhibitor aliskiren (May 2011)
    Aleksandr Korniyenko, MD and Franz H. Messerli, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 722-723; DOI: https://doi.org/10.3949/ccjm.78c.1104
  • Angioedema due to the renin inhibitor aliskiren (May 2011)
    S. Khan
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 722; DOI: https://doi.org/10.3949/ccjm.78c.1103

    Readers comment on the management of atrial fibrillation (April 2011) and on angioedema due to angiotensin-converting inhibitors and related drugs (May 2011).

  • Atrial fibrillation management: Issues of concern (April 2011)
    Chia-Ter Chao, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 720; DOI: https://doi.org/10.3949/ccjm.78c.1101

    Readers comment on the management of atrial fibrillation (April 2011) and on angioedema due to angiotensin-converting inhibitors and related drugs (May 2011).

Pages